Published 12:04 IST, July 4th 2020
Brazil's Anvisa approves clinical trials of China's possible COVID-19 vaccine
Brazil had already authorised the clinical trial of the vaccine ChAdOx1 nCoV-19 (AZD1222) developed by Oxford University in collaboration with AstraZeneca.
null | Image:
self
Advertisement
12:04 IST, July 4th 2020